台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    68.0
  • 漲跌
    ▲3.5
  • 漲幅
    +5.43%
  • 成交量
    177
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-元大-木柵 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-木柵 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/03/2100.000.159.4059.50-0.1226-0.03%
2024/03/0800.00162.1061.00-1214-0.47%
2024/02/26151.8000.0052.1011810.55%
2024/02/0500.000.450.0050.50-0.4164-0.24%
2024/02/0200.00146.0046.10-1153-0.65%
2024/01/1000.00139.2539.50-1230-0.43%
2023/10/1300.00324.1024.10-330-9.89%
2023/07/1700.00122.8522.90-180-1.24%
2023/06/13122.5500.0021.9511170.85%
2023/06/06123.6000.0024.1011390.72%
2023/06/05324.1000.0024.8031372.19%
2023/04/1400.000.119.7520.30-0.197-0.07%
2022/06/2300.001512.3012.30-15157-9.51%
2022/06/15112.8000.0013.0011480.67%
2022/05/12113.7000.0013.7011490.67%
2022/05/10214.1800.0014.4021441.38%
2022/05/0900.001515.0014.45-15143-10.47%
2021/05/2800.00117.4017.40-1484-0.21%
2021/05/27117.4000.0017.4015050.20%
2021/05/1200.00217.8017.80-2377-0.53%
2021/04/23317.1500.0017.1533440.87%
2021/04/225117.5100.0017.255134214.91%
2021/04/213517.7700.0017.753533710.38%
2021/04/20517.9000.0017.9053351.49%
2021/04/192018.0800.0018.10203355.96%
2021/04/14217.753418.2617.30-32328-9.74%
2021/04/133419.7000.0018.203432210.53%
2020/08/1300.00123.9523.50-12,317-0.04%
2020/08/12123.9500.0023.8012,3270.04%
2020/08/1100.006623.1822.60-662,322-2.84%
2020/08/0500.00125.1525.05-12,289-0.04%
2020/08/03125.4500.0026.4012,2730.04%
2020/07/3100.0018424.6224.65-1842,263-8.13% 大賣/鉅額交易
2020/07/3018525.5800.0025.251852,2728.14% 大買/鉅額交易
2020/07/29125.0000.0025.5512,2730.04%
2020/07/2200.00229.8030.00-22,204-0.09%
2020/07/21226.7500.0027.4522,1490.09%
2020/07/1400.00429.6529.60-41,907-0.21%
2020/07/13630.7600.0031.5561,7930.33%
2020/07/1000.00124.9528.70-11,666-0.06%
2020/06/17125.601025.9025.35-91,350-0.67%
2020/06/161024.60925.3425.9011,2940.08%
2020/06/15924.1300.0024.2091,2070.75%
2020/06/1200.00120.6022.00-11,124-0.09%
2020/06/1100.00121.0021.00-11,077-0.09%
2020/05/28219.98817.6418.50-6978-0.61%
2020/05/27723.75119.4519.4569470.63%
2020/05/2500.00118.5019.65-1935-0.11%
2020/05/22317.3700.0017.9039300.32%
2020/05/0600.00113.3512.65-1761-0.13%
2020/05/05112.5000.0012.4017420.13%
2020/04/2900.00111.4011.30-1713-0.14%
2020/04/2800.00511.5811.60-5703-0.71%
2020/04/1529.7000.009.6326850.29%
2020/03/17129.0400.009.00126321.90%
2020/03/162010.0800.0010.00206163.24%
2020/03/13309.3200.009.44306044.96%
2020/03/11611.5500.0011.5065631.06%
2020/03/10112.7500.0012.7515440.18%
2020/03/06114.4000.0014.7515020.20%
2020/02/2500.00112.2512.80-1264-0.38%
2020/01/30111.7000.0011.7511280.78%
2019/12/3000.0019.989.95-169-1.44%
2019/12/0500.0029.709.74-293-2.15%
2019/11/2000.0029.459.42-289-2.22%
2019/11/06210.2500.0010.302882.27%
2019/10/0200.00111.0010.80-1150-0.66%
2019/10/01110.8000.0010.9511530.65%
2019/09/11211.3000.0011.8021701.17%
2019/09/1000.00210.9010.90-2155-1.29%
2019/08/2729.9319.969.9111480.67%
2019/08/0800.00110.8010.75-1148-0.67%
2019/08/07110.7500.0010.7511490.67%
2019/07/19211.7000.0011.7521341.48%
2019/05/2100.00310.2010.15-3102-2.94%
2019/03/20312.5000.0012.5031472.03%
2019/03/1400.00313.4013.40-3138-2.17%
2019/02/13312.5000.0012.6031172.55%
2018/11/1500.00112.8012.80-186-1.16%
2018/11/1200.00113.2013.20-185-1.17%
2018/04/1700.00121.7520.55-1342-0.29%
2018/04/16121.8000.0021.3513290.30%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音